Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials

Affiliations

• ¹ School of Immunology & Microbial Sciences, Kings College London, 5th Floor, Southwark Wing, London, SE1 9RT, UK. manu.shankar-hari@kcl.ac.uk.
• ² Guy's and St Thomas' NHS Foundation Trust, ICU Support Offices, 1st Floor, East Wing, St Thomas' Hospital, London, SE1 7EH, UK. manu.shankar-hari@kcl.ac.uk.
• ³ NHS Blood and Transplant, Level 2, John Radcliffe Hospital, Oxford, OX3 9BQ, UK.
• ⁴ Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
• ⁵ National Microbiology Services, NHS Blood and Transplant, Charcot Road, Colindale, NW9 5BG, UK.
• ⁶ Division of Infection and Immunity, University College of London, London, WC1E 6JF, UK.
• ⁷ Division of Anaesthesia, Department of Medicine, University of Cambridge, Box 93, Addenbrooke's Hospital, Cambridge, CB2 0NUI, UK.